Wednesday, September 23, 2026
Two papers, a psychopharmacology pearl, a psychotherapy pearl and the news.
AI-generated content. This briefing was written by Claude Opus 5.5 and may contain errors. Please verify against the primary source before acting clinically.
| The Paper |
| New research from the psychiatric journals |
Predicting Long-Term Poor Outcomes in Individuals at Clinical High Risk for Psychosis Using Real-World Clinical Data: The OASIS1000 Prospective Study
Logeswaran Y, De Micheli A, Toniol I, et al. World Psychiatry. June 2026.
This 21-year prospective cohort followed 1,000 patients at clinical high risk for psychosis (CHR-P) from a UK early-detection service, using routine clinical data to build a model predicting long-term poor outcomes — transition to psychosis, need for first-episode-level antipsychotic dosing, psychiatric hospitalization, or suicide — beyond the usual short transition-risk window. By 14–18 years, roughly 64% of CHR-P patients had experienced one of these outcomes, and the model showed useful discrimination (C=0.69) built entirely from data a clinic would already have on hand.
|
In practice
CHR-P follow-up shouldn't stop at 1–3 years; a substantial share of poor outcomes emerge over a much longer horizon, and simple EHR-based risk models may help identify who needs continued monitoring. |
Full text doi:10.1002/wps.70063
| The Therapy Evidence |
| Research on what actually works in the room |
Potential Mechanisms of Change in Virtual Reality-Based CBT and Standard CBT for Schizophrenia-Related Paranoia: A Mediation Analysis From the FaceYourFears Trial
Jeppesen UN, Vernal DL, Christensen MJ, et al. Schizophrenia Bulletin Open. July 2026.
This secondary mediation analysis of the 254-patient FaceYourFears trial — which found VR-guided CBT for psychosis (VR-CBTp) and standard CBTp equally effective — tested whether the two treatments work through different theorized mechanisms: safety behaviors, belief inflexibility, and negative core beliefs. None of the hypothesized differential-mediation effects held up in 186 completers: despite far more in-session exposure in the VR arm, safety-behavior change wasn't more influential there, and belief-inflexibility change wasn't more influential with standard CBTp. More in-session VR exposure was actually associated with slightly worse paranoia outcomes.
|
In practice
When two CBT-based psychosis treatments produce equivalent outcomes, don't assume they work through different mechanisms — exposure 'dose' may not be the active ingredient it's often assumed to be, so treatment choice should follow patient preference and access rather than presumed mechanism-matching. |
Full text doi:10.1093/schizbullopen/sgag028
| Past the Boards |
| One advanced clinical point, usually pharmacology |
Lamotrigine's Rash Risk Is a Titration Problem, Not a Dose Problem
Comparative data show rash rates dropping from roughly 27% to 8% when lamotrigine is titrated slowly instead of at the standard schedule, and Stevens-Johnson risk falls by one to two orders of magnitude with the same change — the driver is peak plasma concentration and rate of rise, not the eventual maintenance dose. This is also why the schedule changes with valproate on board: valproate inhibits the UGT enzymes that clear lamotrigine, roughly doubling levels for a given dose, so the co-administration titration is slower and lower than monotherapy. Most reactions surface in the first eight weeks. The practical consequence for a missed-dose restart: don't resume at the prior maintenance dose after any meaningful gap — restart the titration from the beginning, because the protection was never about the dose itself, it was about how slowly the patient got there.
| In the Room |
| A psychotherapy technique, shown in a vignette |
Renegotiating the Contract Is Itself an Intervention, Not an Administrative Reset
TFP's treatment contract isn't signed once and filed away. When a patient begins missing sessions or repeatedly arrives too late for meaningful work, the technique is a tactical renegotiation of the frame, conducted in-session with the same clarification-confrontation logic used on any other material — not a hallway reminder of the rules. Kernberg's approach treats the boundary problem as data about which internal object relation is dominating the transference at that moment, rather than as a compliance issue to solve administratively. The renegotiation names the behavior concretely, links it to the pattern it belongs to, and invites the patient to help design the new limit — collaboration is what keeps the intervention therapeutic rather than punitive. Skipping straight to enforcement treats the frame as furniture instead of clinical material.
|
Vignette
A patient with borderline pathology begins arriving 20–30 minutes late every session, then rushes through whatever's left. Rather than reminding her of the start time, the therapist says: “We agreed on forty-five minutes together. For a month now we've had twenty. I think something about being fully here, on time, has become dangerous — I'd like us to figure out together what happens if we protect the full hour again.” She admits that arriving late lets her avoid a wave of dread she can only manage by smoking beforehand. The renegotiated contract becomes the route into interpreting the avoidance itself. |
| *** |
| That's the five. Go see your first patient. |